Search results
UPFs an Independent Risk Factor for Poor Brain Health
Medscape· 4 days agoConsuming highly processed foods may be harmful to the aging brain, independent of other risk...
Guidelines on Rapid BP Reduction in Stroke Challenged
Medscape· 5 days agoNew findings challenge the practice of rapidly lowering blood pressure (BP) in acute ischemic stroke...
How I Started My Own Walking Tours Business | Entrepreneur
Entrpreneur· 7 days ago"I think the biggest mistake people make when starting out is thinking that this is easy because it...
Portal Use Low Among Minorities, Non-English Speakers
Medscape· 5 days agoClinicians may need to communicate with these patients using means other than patient portals to...
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 3 days agoOncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, presented two abstracts at the 2024 American Society of Clinical ...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 3 days agoFN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention, diagnosis, and treatment of pancreatic ...
Bristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology...
Morningstar· 4 days agoBristol Myers Squibb to Present Data at the 2024 American Society of Clinical Psychopharmacology Annual Meeting Consistent with short-term studies, KarXT was not associated with clinically meaningful changes in movement disorder scale scores and a
Adena Power Selected for Army SBIR Phase 1 Award
Digital Journal· 3 days agoJasvant Modi Funds Groundbreaking PhD Scholarship in Jain Studies at SOAS University of London More from Digital Journal Let’s waltz! Vienna ball season back in full swing ...
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO...
Morningstar· 4 days agoOPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDACThe encouraging duration of response (median ...
Why some researchers are approaching giftedness as a form of neurodivergence
WHYY· 7 days agoThis is one reason why scientists think that a lot of gifted kids struggle with executive...